Amphetamine, past and present – a pharmacological and clinical perspectiveDavid J. Heal, David Nutt, Sharon L. Smith et al.|Journal of Psychopharmacology|2013Cited by 614
The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safetyDavid J. Heal, Sharon L. Smith, Sharon C. Cheetham|Neuropharmacology|2009Cited by 197
Selective 5-HT6 receptor ligands: Progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disordersDavid J. Heal, Helmut Buschmann, Xavier Codony et al.|Pharmacology & Therapeutics|2007Cited by 183
New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHDDavid J. Heal, Helen L. Rowley, Sharon L. Smith et al.|Pharmacology Biochemistry and Behavior|2008Cited by 100
Regulatory challenges for new drugs to treat obesity and comorbid metabolic disordersDavid J. Heal, Sharon L. Smith, Jane Gosden|British Journal of Clinical Pharmacology|2009Cited by 87